Skip to Content

130 (Mycophenolate mofetil 250 mg)

This pill with imprint "130" is Blue & White, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is supplied by Zydus Pharmaceuticals.

Mycophenolate mofetil is used in the treatment of pulmonary fibrosis; nephrotic syndrome; autoimmune hepatitis; systemic lupus erythematosus; organ transplant, rejection prophylaxis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 130

Mycophenolate mofetil

250 mg
Blue & White
19.00 mm
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Zydus Pharmaceuticals
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 1
FD&C Red No. 3
magnesium stearate
sodium lauryl sulfate
titanium dioxide
povidone k90
pregelatinized corn starch
silicon dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.